NeoGenomics (NASDAQ:NEO) Reaches New 52-Week Low After Analyst Downgrade
NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) hit a new 52-week low on Wednesday after The Goldman Sachs Group lowered their price target on the stock from $15.00 to $10.00. The Goldman Sachs Group currently has a buy rating on the stock. NeoGenomics traded as low as $6.40 and last traded at $6.58, with a […]
NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) hit a new 52-week low on Wednesday after The Goldman Sachs Group lowered their price target on the stock from $15.00 to $10.00. The Goldman Sachs Group currently has a buy rating on the stock. NeoGenomics traded as low as $6.40 and last traded at $6.58, with a […]
